Skip to main content
Fig. 6 | BMC Bioinformatics

Fig. 6

From: Integrative analysis of mutated genes and mutational processes reveals novel mutational biomarkers in colorectal cancer

Fig. 6

Gender and geographical distributions of the patients in each subtype. a Gender distributions. Our gender analysis shows that 52.3% of the patients in SC7 are female while 76.9% and 60.9% of patients in SC5 and SC3 are male, respectively. b Geographical distributions. Our geographical distribution analysis shows that 21 patients in SC7 are from China and 68.2% of patients in SC1 are from USA (e.g. COAD project)

Back to article page